Showing Form 4 filings for ANIP
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Ani Pharmaceuticals Inc
Price
$71.22
Shares
5,400
Ownership
328,289
Value/Share
Lalwani Nikhil
Pres, CEO
Unknown
Industry
$72.87
2,850
166,143
Carey Stephen P.
SVP, CFO
$71.89
333,689
$73.00
168,993